Glicosaminoglicani solforati includenti l’eparina, l’eparina a basso peso molecolare e i loro derivati per l’impiego nel trattamento terapeutico di anemie e per l’inibizione dell’espressione di epcidina
A cura di: POLA AnnalisaPOLI Maura Sfoglia la rubrica The invention relates to a new medical application of sulphated glycosaminoglycans, particularly heparin, low molecular weight heparin and derivatives thereof, in the therapeutic treatment of anaemia, in particular iron deficiency anaemia, chronic disease anaemia (also known as inflammatory anaemia) and iron-refractory iron-deficient anaemia (IRIDA). The mechanism […]